The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.
Highlights of the Report:
- In-depth analysis of various insights, namely, Orthopedic Devices Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Orthopedic Devices Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586
Key Players Operating in The Orthopedic Devices Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Smith & Nephew
- Stryker
- Zimmer Biomet
- Medical Devices Business Services, Inc. (Johnson & Johnson)
- NuVasive, Inc.
- Medtronic
- Integra LifeSciences
- Wright Medical Group N.V.
- Össur Corporate
- Globus Medical
- Other prominent players
Segment-
Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures
Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints. The arthroscopy devices segment is likely to expand at fast pace owing to the increasing emergence of novel products and upsurging cases of soft tissue injuries related to sports
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthopedic-devices-market-102586
Regional Analysis-
High Purchasing Power of the Masses to Favor Growth in Asia Pacific
Geographically, the market is fragmented into Latin America, Asia Pacific, the Middle East and Africa, North America, and Europe. Amongst these, North America procured USD 23.86 billion orthopedic medical devices market revenue in 2018. This growth is attributable to the presence of adequate reimbursement policies, as well as surging incidence of orthopedic surgeries. Apart from these, availability of state-of-the-art treatment options and rising awareness among the patient pool regarding the presence of these advanced devices would contribute to the market growth.
More Trending Topics from Fortune Business Insights:
Pulse Oximeters Market 2020: Global Industry Reports, Future Demand, Insights, Share Outlook by 2025
The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world.
As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures.
Besides, around 30% of seniors fall per year.
It is further leading to higher number of orthopedic injuries.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market.
They are as follows:Smith & NephewStrykerZimmer BiometMedical Devices Business Services, Inc. (Johnson & Johnson)NuVasive, Inc.MedtronicIntegra LifeSciencesHigh Purchasing Power of the Masses to Favor Growth in Asia PacificGeographically, the market is fragmented into Latin America, Asia Pacific, the Middle East and Africa, North America, and Europe.
Amongst these, North America procured USD 23.86 billion orthopedic medical devices market revenue in 2018.
The global anticoagulants market size is projected to reach 45.50 billion by the end of 2026.
According to a report published by Fortune Business Insights, titled “Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” the market was worth USD 21.45 billion in 2018 and will exhibit a CAGR of 9.9% during the forecast period,2019-2026.Increasing Number of Company Mergers Will Aid Market GrowthSeveral growth stimulating factors have been analyzed and discussed in detail.
Among all factors, the increasing number of company mergers have had the highest impact on the market.
In February 2019, Novartis AG and Blackstone’s LifeSciences announced the launch of Anthos Therapeutics.
The company is aiming for the research and development of drugs that include anticoagulants as a prime pipeline candidate.
Increasing number of drug approvals is another factor that has constituted an increase in the global anticoagulants market size in recent years.
Market Analysis: Global Plasma Fractionation MarketGlobal plasma fractionation market is registering a substantial CAGR of 7.10% in the forecast period of 2019-2026.
This rise in the market can be attributed to the surging incidence of respiratory disease and increasing aging population.Global Plasma Fractionation Market By Product (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Other Products), Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Other Applications), End User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026Get More Insights About the Global Trends Impacting the Future of Plasma Fractionation Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-plasma-fractionational-marketMarket Definition: Global Plasma Fractionation MarketPlasma fractionation is a method of dividing different plasma parts.
It is used to protect and treat life-threatening illnesses triggered by trauma, immunological illnesses, and infections.
A primary role of plasma fractionation is the removal or inactivation of viruses and prions.Market Drivers· Surging incidence of respiratory diseases is driving the growth of the market· Increasing investment in research and development is helping the market to grow· Various government initiatives is flourishing the growth of the market· Increasing aging population drives the growth of the marketMarket Restraints· High cost of plasma products hinders the growth of the market· Strict regulations of government restrict the growth of the market· Increasing substitutes of plasma products hampers the growth of the marketKnow more about this report https://www.databridgemarketresearch.com/reports/global-plasma-fractionational-marketCompetitive Analysis:Global plasma fractionation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of plasma fractionation market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.Key Market Competitors:Few of the major market competitors currently working in the global plasma fractionation market are CSL Plasma, Grifols, S.A., Shire, Octapharma, Kedrion S.p.A, BPL Inc., Sanquin, Biotest AG, LFB S.A., Japan Blood Products Organization, China Biologic Products Holdings, Inc., GREEN CROSS CORP, Shanghai RAAS, Baxter, Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Novasep Inc., Pall Corporation, Merck KGaA and Boccard among others.Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-plasma-fractionational-marketResearch Methodology: Global Plasma Fractionation MarketData collection and base year analysis is done using data collection modules with large sample sizes.
Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
The global regenerative medicine market generated a revenue of $8,186.9 million in 2019 and it is predicted to advance at a CAGR of 16.3% between 2020 and 2030.
The market is also predicted to reach a valuation of $39,012.0 million by 2030.
The major factors driving the advancement of the market are the rapid technological advancements, the rising incidence of genetic and chronic diseases, and the surging population of geriatric people around the world.Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market/report-sampleAccording to various reports, around one in every three adults all over the world suffer from various chronic health conditions.
Moreover, as per the World Health Organization (WHO), nearly 17.9 million people across the world die because of cardiovascular diseases every year.
Besides this, the soaring investments being made by various governments in research and development (R) activities in the domain of regenerative medicine are also fueling the market expansion across the world.Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=regenerative-medicine-marketDepending on application, the regenerative medicine market is divided into oncology, musculoskeletal, dental, wound care, and ocular categories.
Out of these, the musculoskeletal category recorded the highest growth in the market during the last few years and this trend is predicted to continue in the coming years as well.
